Thank you for sharing!

Your article was successfully shared with the contacts you provided.
Under the Cures Act, it will be faster and easier for pharmaceutical companies to win approvals for new drugs. (Photo: Getty)

The bipartisan 21st Century Cures Act, headed to the Senate after passage in the House by a huge margin—392 to 26—is meeting with mixed reactions by many.


Join BenefitsPRO

Don’t miss crucial news and insights you need to navigate the shifting employee benefits industry. Join BenefitsPRO.com now!

  • Unlimited access to BenefitsPRO.com - your roadmap to thriving in a disrupted environment
  • Access to other award-winning ALM websites including ThinkAdvisor.com and Law.com
  • Exclusive discounts on BenefitsPRO.com and ALM events.

Already have an account? Sign In Now
Join BenefitsPRO

Copyright © 2019 ALM Media Properties, LLC. All Rights Reserved.